Bral

基本解釋

IGF-1 takes part in the pathophysiological procedure of acute cere bral infarction.
IGF-1參與了急性腦梗死的病理生理過程。
Objective To investigate neuronal DNA damage a nd the regulation of Bcl-2after cere bral ischemia and reperfusion.
目的研究腦缺血再灌注(IR)后神經(jīng)元DNA損傷及Bcl-2的調(diào)控作用。
Objective To study a new thrombolytic therapy of acute cere bral infarction by combined use of urokinase(UK) and protaglandin E 1(PGE 1).
目的研究探索聯(lián)合溶栓劑尿激酶 (Urokinase ,UK)和前列腺素E1(ProtaglandinE1,PGE1)對(duì)急性腦梗死患者進(jìn)行靜脈溶栓的臨床療效觀察。
The treatment consists of hemostasis,mild dose of mannitol and cere bral cell active drug,but hyperbaric oxygenation should be used carefully.
治療給予止血、小劑量甘露醇降顱壓、腦細(xì)胞賦活劑及慎重高壓氧治療。
Methods 83 patients with type2 diabetes m ellitus (group A), 20 patients with type2 diabetes mellitus associated with cere bral infarction (group B) and 35 healthy subjects (group C) were chosen in the s tudy.
方法選取2型糖尿病患者83例(A組)、合并腦梗塞患者20例(B組)、健康對(duì)照者35例(C組)作為研究對(duì)象。